兒科導管市場 - 按產品類型、材料、最終用途 - 全球預測，2024 年 - 2032 年

在導管設計技術創新、微創手術需求不斷成長、醫療保健支出增加以及兒科醫療保健意識不斷提高的推動下，2024-2032年全球兒科導管市場將以7.1%的複合年成長率成長。

泌尿道感染（UTI）、膀胱輸尿管逆流（VUR）和神經性膀胱功能障礙等兒科泌尿系統疾病的盛行率不斷增加，是兒科導管市場成長的重要驅動力。

根據 BMC Infectious Drugs 的數據，泌尿道感染是全球第二大流行的傳染病，每年影響超過 1.5 億人。泌尿道感染的特徵是尿路細菌感染，需要及時診斷和治療以預防併發症，通常會使用導尿術採集尿液樣本和給藥。

同樣，由神經系統疾病引起的神經源性膀胱功能障礙需要定期插入導尿管以防止尿瀦留和相關併發症。兒科導管的需求不斷成長，反映出兒科泌尿科對有效診斷和治療干預措施的需求不斷增加，促使製造商創新和開發客製化的導管解決方案，以滿足兒科患者的獨特需求。

兒科導管市場根據產品類型、材料、最終用途和地區進行分類。

由於泌尿導管廣泛用於診斷和治療各種兒科泌尿疾病，泌尿導管細分市場將在 2024 年至 2032 年期間獲得可觀的效益。泌尿導管，包括 Foley 導管、間歇性導管和外置導管，在治療兒科患者的尿瀦留、尿失禁和膀胱功能障礙方面發揮著至關重要的作用。泌尿導管設計的不斷創新，例如親水塗層、抗菌特性和兒科專用尺寸，正在進一步推動擴張。

到 2032 年，由於對門診手術的偏好日益增加以及對具有成本效益的醫療保健服務模式的日益關注，門診手術中心 (ASC) 細分市場將佔據一定的兒科導管市場佔有率。 ASC 為兒科導管插入手術提供了便捷高效的環境，能夠及時進行干預、減少住院時間並提高患者滿意度。此外，對 ASC 基礎設施的投資不斷增加以及門診網路的不斷擴大正在推動市場成長。

在快速城市化、不斷增加的醫療保健支出和迅速成長的兒科人口的推動下，到 2032 年，亞太地區兒科導管市場將獲得可觀的估值。中國、印度和日本等國家的兒科醫療基礎設施發展迅猛，同時也越來越重視預防性和治療性兒科泌尿外科干預措施。此外，旨在改善兒科醫療保健取得和負擔能力的有利政府措施進一步推動了該地區的市場成長。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 泌尿系統疾病盛行率增加
    • 導管設計的技術進步
    • 全球兒科人口不斷增加
    • 兒童微創外科手術的需求不斷成長
  • 產業陷阱與挑戰
    • 關於導管相關併發症的擔憂
    • 兒科導尿管成本高
• 成長潛力分析
• 監管環境
• 技術景觀
• 波特的分析
• PESTEL分析
• 定價分析
• 未來市場趨勢
• 缺口分析

第 4 章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按產品類型，2018 年 - 2032 年

• 主要趨勢
• 心血管導管
• 泌尿科導管
• 靜脈導管
• 神經血管導管
• 特種導管

第 6 章：市場估計與預測：按材料分類，2018 - 2032 年

• 主要趨勢
• 聚氯乙烯
• 矽酮
• 聚氨酯
• 乳膠
• 其他材料

第 7 章：市場估計與預測：按最終用途，2018 - 2032 年

• 主要趨勢
• 醫院
• 專科診所
• 門診手術中心
• 其他最終用戶

第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第 9 章：公司簡介

• Becton, Dickinson and Company
• Boston Scientific Corporation
• Coloplast Corp
• Cook Medical
• Edwards Lifesciences Corporation
• Getinge AB
• ICU Medical, Inc.
• Johnson & Johnson Private Limited
• Medline Industries, LP
• Medtronic, Plc.

Global Pediatric Catheters Market will grow at 7.1% CAGR during 2024-2032, driven by technological innovations in catheter design, growing demand for minimally invasive procedures, increasing healthcare expenditure, and rising awareness about pediatric healthcare.

The increasing prevalence of pediatric urological disorders, such as urinary tract infections (UTIs), vesicoureteral reflux (VUR), and neurogenic bladder dysfunction, is a significant driver of growth in the pediatric catheters market.

According to BMC Infectious Diseases, UTIs rank as the second most prevalent infectious disease worldwide, impacting over 150 million individuals annually. UTIs, characterized by bacterial infection in the urinary tract, necessitate prompt diagnosis and treatment to prevent complications, with catheterization commonly employed for urine sample collection and medication administration.

Similarly, neurogenic bladder dysfunction, resulting from neurological conditions, mandates regular catheterization to prevent urinary retention and associated complications. The rising demand for pediatric catheters reflects the increasing need for effective diagnostic and therapeutic interventions in pediatric urology, prompting manufacturers to innovate and develop tailored catheter solutions to meet the unique requirements of pediatric patients.

The Pediatric Catheters Market is classified based on product type, material, end-use, and region.

The urology catheters segment will amass appreciable gains over 2024-2032, owing to their widespread use in the diagnosis and treatment of various pediatric urological conditions. Urology catheters, including Foley catheters, intermittent catheters, and external catheters, play a vital role in managing urinary retention, incontinence, and bladder dysfunction in pediatric patients. The continuous innovation in urology catheter designs, such as hydrophilic coatings, antimicrobial properties, and pediatric-specific sizes, is further driving expansion.

Ambulatory surgical centers (ASCs) segment will capture a modest pediatric catheters market share by 2032, driven by the increasing preference for outpatient procedures and the growing focus on cost-effective healthcare delivery models. ASCs offer a convenient and efficient setting for pediatric catheterization procedures, enabling timely interventions, reduced hospital stays, and enhanced patient satisfaction. Moreover, the rising investments in ASC infrastructure and the expanding network of outpatient clinics are bolstering market growth.

Asia Pacific Pediatric Catheters Market will garner a decent valuation by 2032, fueled by rapid urbanization, increasing healthcare expenditure, and a burgeoning pediatric population. Countries such as China, India, and Japan are witnessing a surge in pediatric healthcare infrastructure development, coupled with a growing emphasis on preventive and therapeutic pediatric urology interventions. Moreover, favorable government initiatives aimed at improving pediatric healthcare access and affordability are further propelling market growth in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast calculations
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of urological disorders
    • 3.2.1.2 Technological advancements in catheter design
    • 3.2.1.3 Rising pediatric population globally
    • 3.2.1.4 Growing demand for minimally invasive surgical procedures in pediatrics
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Concerns regarding catheter-associated complications
    • 3.2.2.2 High cost of pediatric catheters
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis
• 3.8 Pricing analysis
• 3.9 Future market trends
• 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Cardiovascular catheters
• 5.3 Urology catheters
• 5.4 Intravenous catheters
• 5.5 Neurovascular catheters
• 5.6 Specialty catheters

Chapter 6 Market Estimates and Forecast, By Material, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Polyvinyl chloride
• 6.3 Silicone
• 6.4 Polyurethane
• 6.5 Latex
• 6.6 Other materials

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Specialty clinics
• 7.4 Ambulatory surgical centers
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Becton, Dickinson and Company
• 9.2 Boston Scientific Corporation
• 9.3 Coloplast Corp
• 9.4 Cook Medical
• 9.5 Edwards Lifesciences Corporation
• 9.6 Getinge AB
• 9.7 ICU Medical, Inc.
• 9.8 Johnson & Johnson Private Limited
• 9.9 Medline Industries, LP
• 9.10 Medtronic, Plc.